---
title: "Summit Therapeutics Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e1cbe79e-1c27-4517-a4e5-697ce7d65a7f
json: https://whiteintel.dev/api/public/dossier/e1cbe79e-1c27-4517-a4e5-697ce7d65a7f
identifier: gb-coh:3262870
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Summit Therapeutics Inc.

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:3262870`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e1cbe79e-1c27-4517-a4e5-697ce7d65a7f  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e1cbe79e-1c27-4517-a4e5-697ce7d65a7f  

## Ownership & control

### Holdings / subsidiaries

- **SUMMIT THERAPEUTICS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/aeec3fc4-8728-54fd-bd16-34028c94213a

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Summit Therapeutics Inc.**. Human view: https://whiteintel.dev/entity/e1cbe79e-1c27-4517-a4e5-697ce7d65a7f · Structured JSON: https://whiteintel.dev/api/public/dossier/e1cbe79e-1c27-4517-a4e5-697ce7d65a7f._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._